Complex karyotype with clonal evolution in a MDS/MPN case MDS/MPN olgusunda klonal evolüsyon gösteren kompleks karyotip bulguları


KURU R. D., ÇIRAKOĞLU A., YILMAZ Ş., EKİZOĞLU S., ARGÜDEN Y., ÖNGÖREN Ş., ...Daha Fazla

Pamukkale Medical Journal, cilt.12, sa.3, ss.585-590, 2019 (Scopus, TRDizin)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 12 Sayı: 3
  • Basım Tarihi: 2019
  • Doi Numarası: 10.31362/patd.557577
  • Dergi Adı: Pamukkale Medical Journal
  • Derginin Tarandığı İndeksler: Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.585-590
  • Anahtar Kelimeler: bone marrow, chromosome 11 abnormalities, idic(18), MDS/MPN, trisomy 18
  • Sağlık Bilimleri Üniversitesi Adresli: Hayır

Özet

Myelodysplastic/myeloproliferative neoplasms (MDS/MPN) are clonal myeloid disorders that have both dysplastic and proliferative features. Pathophysiology of MDS/MPN includes abnormalities in regulation of myeloid pathways. Patients with MDS/MPN do not have BCR/ABL fusion gene. Abnormalities in regulation of the RAS pathway of signaling proteins appear to be a common finding in these diseases. In this study we present a MDS/ MPN case with complex karyotype. By Real Time-PCR, BCR/ABL p210 transcript (MBCR) was negative, and by allele-specfic PCR, JAK2 V617F mutation was positive. By cytogenetics, a complex karyotype was observed with, idic (18)(p11.2), t(11;idic(18))(p11.1;q11) and dic(11;18)(q24;p11) which were formed through clonal evolution. The results included different rearrangements and partial gain of chromosome 18. Rearrangements involving chromosomes 11 and 8 have been previously reported in hematological malignancies but with different breakpoints from ours. Trisomy/ partial trisomy 18 had been reported in lymphoproliferative disorders and MDS. The genes on chromosome 18 are considered important, being associated with carcinogenesis. BCL-2 family, whose members are important apoptosis regulators, is localized on the long arm of chromosome 18. Cytogenetic findings we present are remarkable as target regions in cancer genetics and alternative treatment research.